ABP
Price
$0.23
Change
+$0.01 (+4.55%)
Updated
Jun 26, 04:59 PM (EDT)
Capitalization
13.56M
MNKD
Price
$3.77
Change
-$0.08 (-2.08%)
Updated
Jun 26 closing price
Capitalization
1.15B
40 days until earnings call
Interact to see
Advertisement

ABP vs MNKD

Header iconABP vs MNKD Comparison
Open Charts ABP vs MNKDBanner chart's image
Abpro Holdings
Price$0.23
Change+$0.01 (+4.55%)
Volume$59.65K
Capitalization13.56M
MannKind
Price$3.77
Change-$0.08 (-2.08%)
Volume$2.3M
Capitalization1.15B
ABP vs MNKD Comparison Chart in %
Loading...
ABP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MNKD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABP vs. MNKD commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABP is a StrongBuy and MNKD is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2025
Stock price -- (ABP: $0.22 vs. MNKD: $3.77)
Brand notoriety: ABP and MNKD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABP: 37% vs. MNKD: 110%
Market capitalization -- ABP: $13.56M vs. MNKD: $1.15B
ABP [@Biotechnology] is valued at $13.56M. MNKD’s [@Biotechnology] market capitalization is $1.15B. The market cap for tickers in the [@Biotechnology] industry ranges from $301.01B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABP’s FA Score shows that 1 FA rating(s) are green whileMNKD’s FA Score has 0 green FA rating(s).

  • ABP’s FA Score: 1 green, 4 red.
  • MNKD’s FA Score: 0 green, 5 red.
According to our system of comparison, both ABP and MNKD are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABP’s TA Score shows that 2 TA indicator(s) are bullish while MNKD’s TA Score has 5 bullish TA indicator(s).

  • ABP’s TA Score: 2 bullish, 3 bearish.
  • MNKD’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, MNKD is a better buy in the short-term than ABP.

Price Growth

ABP (@Biotechnology) experienced а +6.70% price change this week, while MNKD (@Biotechnology) price change was -1.05% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.59%. For the same industry, the average monthly price growth was +34.25%, and the average quarterly price growth was +14.95%.

Reported Earning Dates

ABP is expected to report earnings on Apr 15, 2025.

MNKD is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+3.59% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MNKD($1.15B) has a higher market cap than ABP($13.6M). MNKD YTD gains are higher at: -41.369 vs. ABP (-87.542). MNKD has higher annual earnings (EBITDA): 82.6M vs. ABP (-10.08M). MNKD has more cash in the bank: 182M vs. ABP (1.26M). ABP has less debt than MNKD: ABP (3.25M) vs MNKD (47.2M). MNKD has higher revenues than ABP: MNKD (298M) vs ABP (183K).
ABPMNKDABP / MNKD
Capitalization13.6M1.15B1%
EBITDA-10.08M82.6M-12%
Gain YTD-87.542-41.369212%
P/E RatioN/A37.70-
Revenue183K298M0%
Total Cash1.26M182M1%
Total Debt3.25M47.2M7%
FUNDAMENTALS RATINGS
MNKD: Fundamental Ratings
MNKD
OUTLOOK RATING
1..100
56
VALUATION
overvalued / fair valued / undervalued
1..100
49
Fair valued
PROFIT vs RISK RATING
1..100
56
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
85
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABPMNKD
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
50%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
19%
Bearish Trend 2 days ago
77%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
43%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
50%
Bearish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 17 days ago
48%
Bullish Trend 24 days ago
81%
Declines
ODDS (%)
Bearish Trend 7 days ago
73%
Bearish Trend 14 days ago
80%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
87%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
71%
View a ticker or compare two or three
Interact to see
Advertisement
ABP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MNKD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ENGN3.590.33
+10.12%
enGene Holdings
SLE4.680.33
+7.64%
Super League Enterprise Inc
FLEX50.091.07
+2.18%
Flex Ltd
TBBB27.430.23
+0.85%
BBB Foods
XERS4.740.03
+0.64%
Xeris Biopharma Holdings

ABP and

Correlation & Price change

A.I.dvisor tells us that ABP and NGNE have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ABP and NGNE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABP
1D Price
Change %
ABP100%
+2.76%
NGNE - ABP
33%
Poorly correlated
-1.84%
FBIO - ABP
30%
Poorly correlated
+2.78%
QSI - ABP
25%
Poorly correlated
+1.49%
SCPH - ABP
24%
Poorly correlated
+0.25%
MNKD - ABP
24%
Poorly correlated
-2.08%
More